Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Hongchang International (HCIL) Research & Development (2016)

Hongchang International (HCIL) has disclosed Research & Development for 6 consecutive years, with $2539.0 as the latest value for Q3 2016.

  • Quarterly Research & Development fell 95.27% to $2539.0 in Q3 2016 from the year-ago period, while the trailing twelve-month figure was $54199.0 through Dec 2016, down 74.77% year-over-year, with the annual reading at $54198.0 for FY2016, 74.77% down from the prior year.
  • Research & Development hit $2539.0 in Q3 2016 for Hongchang International, down from $15182.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $64986.0 in Q4 2012 to a low of $2539.0 in Q3 2016.
  • Historically, Research & Development has averaged $49470.1 across 5 years, with a median of $54698.0 in 2014.
  • Biggest five-year swings in Research & Development: skyrocketed 35.06% in 2012 and later crashed 95.27% in 2016.
  • Year by year, Research & Development stood at $64986.0 in 2012, then decreased by 6.98% to $60453.0 in 2013, then dropped by 9.13% to $54933.0 in 2014, then fell by 2.33% to $53653.0 in 2015, then plummeted by 95.27% to $2539.0 in 2016.
  • Business Quant data shows Research & Development for HCIL at $2539.0 in Q3 2016, $15182.0 in Q2 2016, and $36478.0 in Q1 2016.